Literature DB >> 3117499

Determinants of hypercapnia in occlusive sleep apnea syndrome.

J A Leech1, E Onal, P Baer, M Lopata.   

Abstract

To assess the relative contributions of age, gender, obesity, pulmonary function, and the severity of sleep-induced respiratory abnormalities to the development of alveolar hypoventilation in patients with occlusive sleep apnea syndrome, prospective data from III patients with occlusive sleep apnea were analyzed by stepwise logistic and multiple regression techniques. The significant variables in a logistic regression model predicting the presence of hypercapnia were daytime arterial oxygen pressure (PaO2; p less than 0.0001) and gender (p less than 0.04), the latter reflecting the higher number of hypercapnic women in our patient population. Multiple regression analysis performed in the hypercapnic group to study the determinants of the severity of elevation of arterial carbon dioxide tension (PaCO2) revealed significant contribution from the PaO2, the apnea-plus-hypopnea index (AHI), and the percent predicted forced vital capacity (r2 = 0.56; p less than 0.0001), whereas in the normocapnic patients, PaCO2 related to PaO2 only. These results suggest that daytime hypoxemia, mechanical impairment of the respiratory system due to obesity or obstructive airway disease (or both), and the severity of sleep-induced respiratory abnormalities as assessed by AHI contribute to the severity of carbon dioxide retention in patients with occlusive sleep apnea in a multifactorial fashion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117499     DOI: 10.1378/chest.92.5.807

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Obesity Hypoventilation Syndrome Epidemiology and Diagnosis.

Authors:  Jay S Balachandran; Juan Fernando Masa; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2014-09

2.  Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing.

Authors:  Vladimir M Macavei; Kristofer J Spurling; Janine Loft; Himender K Makker
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

3.  Hypercapnia in overlap syndrome: possible determinant factors.

Authors:  Onofrio Resta; Maria Pia Foschino Barbaro; Caterina Brindicci; Maria Cristina Nocerino; Gennaro Caratozzolo; Monica Carbonara
Journal:  Sleep Breath       Date:  2002-03       Impact factor: 2.816

4.  Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome.

Authors:  R Jokic; T Zintel; G Sridhar; C G Gallagher; M F Fitzpatrick
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

5.  Sleep effects on breathing and respiratory diseases.

Authors:  Sumer S Choudhary; Sanjiw R Choudhary
Journal:  Lung India       Date:  2009-10

6.  Is apnea hypopnea index a good predictor for obesity hypoventilation syndrome in patients with obstructive sleep apnea?

Authors:  Ahmed BaHammam
Journal:  Sleep Breath       Date:  2007-09       Impact factor: 2.816

7.  Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea.

Authors:  Babak Mokhlesi; Aiman Tulaimat; Arthur T Evans; Yue Wang; Abed-Alrahman Itani; Hesham A Hassaballa; James J Herdegen; Edward J Stepanski
Journal:  J Clin Sleep Med       Date:  2006-01-15       Impact factor: 4.062

Review 8.  Sleep-related breathing disorders. 4. Consequences of sleep disordered breathing.

Authors:  K A Ferguson; J A Fleetham
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

9.  Pulmonary function in the morbidly obese.

Authors:  Joshua A Saliman; Joshua O Benditt; David R Flum; Brant K Oelschlager; E Patchen Dellinger; Christopher H Goss
Journal:  Surg Obes Relat Dis       Date:  2008-07-17       Impact factor: 4.734

Review 10.  Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.

Authors:  Carlos Zamarrón; Vanesa García Paz; Emilio Morete; Felix del Campo Matías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.